Filing Details

Accession Number:
0001179110-13-006722
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-11 21:45:02
Reporting Period:
2013-04-10
Filing Date:
2013-04-11
Accepted Time:
2013-04-11 21:45:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1012140 Onyx Pharmaceuticals Inc ONXX Biological Products, (No Disgnostic Substances) (2836) 943154463
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1282660 R Julianna Wood C/O Onyx Pharmaceuticals, Inc.
249 E. Grand Ave.
South San Francisco CA 94080
Vp, Public Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-04-10 547 $35.18 19,921 No 4 M Direct
Common Stock Acquisiton 2013-04-10 220 $28.55 20,141 No 4 M Direct
Common Stock Acquisiton 2013-04-10 1,198 $37.68 21,339 No 4 M Direct
Common Stock Acquisiton 2013-04-10 619 $30.28 21,958 No 4 M Direct
Common Stock Acquisiton 2013-04-10 600 $28.55 22,558 No 4 M Direct
Common Stock Acquisiton 2013-04-10 146 $30.28 22,704 No 4 M Direct
Common Stock Disposition 2013-04-10 3,330 $95.00 19,374 No 4 S Direct
Common Stock Acquisiton 2013-04-10 510 $30.28 19,884 No 4 M Direct
Common Stock Acquisiton 2013-04-10 440 $28.55 20,324 No 4 M Direct
Common Stock Acquisiton 2013-04-10 1,437 $37.68 21,761 No 4 M Direct
Common Stock Acquisiton 2013-04-10 3,645 $35.18 25,406 No 4 M Direct
Common Stock Acquisiton 2013-04-10 586 $28.55 25,992 No 4 M Direct
Common Stock Disposition 2013-04-10 6,618 $95.00 19,374 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-04-10 547 $0.00 547 $35.18
Common Stock Stock Option (Right to Buy) Disposition 2013-04-10 3,645 $0.00 3,645 $35.18
Common Stock Stock Option (Right to Buy) Disposition 2013-04-10 220 $0.00 220 $28.55
Common Stock Stock Option (Right to Buy) Disposition 2013-04-10 600 $0.00 600 $28.55
Common Stock Stock Option (Right to Buy) Disposition 2013-04-10 440 $0.00 440 $28.55
Common Stock Stock Option (Right to Buy) Disposition 2013-04-10 586 $0.00 586 $28.55
Common Stock Stock Option (Right to Buy) Disposition 2013-04-10 1,198 $0.00 1,198 $37.68
Common Stock Stock Option (Right to Buy) Disposition 2013-04-10 1,437 $0.00 1,437 $37.68
Common Stock Stock Option (Right to Buy) Disposition 2013-04-10 619 $0.00 619 $30.28
Common Stock Stock Option (Right to Buy) Disposition 2013-04-10 146 $0.00 146 $30.28
Common Stock Stock Option (Right to Buy) Disposition 2013-04-10 510 $0.00 510 $30.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,760 2021-03-31 No 4 M Direct
9,115 2021-03-31 No 4 M Direct
2,173 2019-03-31 No 4 M Direct
1,573 2019-03-31 No 4 M Direct
1,133 2019-03-31 No 4 M Direct
547 2019-03-31 No 4 M Direct
19,166 2022-03-29 No 4 M Direct
17,729 2022-03-29 No 4 M Direct
7,291 2020-03-31 No 4 M Direct
7,145 2020-03-31 No 4 M Direct
6,635 2020-03-31 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 200 Indirect Children's Trust
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. The shares were sold at prices ranging from $95.00 to $95.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. 12.5% of the shares subject to the option become exercisable 6 months following the date of grant. The remaining shares become exercisable in equal monthly installments over the following 42 months for a total vesting schedule of 48 months.